VivoSim Labs, Inc. Gain (Loss) on Termination of Lease
VivoSim Labs, Inc. (VIVS) reported Gain (Loss) on Termination of Lease of $0 for the 12-month period ending 2021-03-31, per its 10-K filed 2021-06-15.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2021-06-15
- VivoSim Labs, Inc. gain (loss) on termination of lease for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. gain (loss) on termination of lease for the quarter ending 2019-12-31 was $525.00K.
- VivoSim Labs, Inc. gain (loss) on termination of lease for the quarter ending 2018-12-31 was $0.00.
- VivoSim Labs, Inc. gain (loss) on termination of lease for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- VivoSim Labs, Inc. gain (loss) on termination of lease for fiscal 2020 was $525.00K.
- VivoSim Labs, Inc. gain (loss) on termination of lease for fiscal 2019 was $0.00.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|
| 2021-03-31 | $0.00 10-K · filed 2021-06-15 | ||
| 2020-12-31 | $0.00 10-Q · filed 2021-02-08 | $0.00 10-Q · filed 2021-02-08 | |
| 2020-03-31 | $525.00K 10-K · filed 2021-06-15 | ||
| 2019-12-31 | $525.00K 10-Q · filed 2021-02-08 | $525.00K 10-Q · filed 2021-02-08 | |
| 2019-03-31 | $0.00 10-K · filed 2020-05-28 | ||
| 2018-12-31 | $0.00 10-Q · filed 2020-02-10 | $0.00 10-Q · filed 2020-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |